The ferroptosis-enhancing effects were markedly amplified by co-treatment with the Akt inhibitor MK-2206, while pharmacological activation of Akt (SC79) or mTOR (MHY1485) effectively rescued HNSCC cells from DDR1 knockdown/CIR-induced ferroptosis. The gene discussed is MTOR; the disease is head and neck squamous cell carcinoma.